Moreover, circulating and tissue-accumulated levels of AGEs are a biomarker to predict future cardiovascular events and death in patients with diabetes, thus suggesting that the blockade of the AGE-RAGE axis in macrophages is a novel therapeutic target for preventing atherosclerotic cardiovascular disease in diabetes [35,36,37,38]. Here, RENBP is linked to diabetes mellitus.